CKS1BP7

Across TCGA pan-cancer cohorts, CKS1BP7 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of CKS1BP7’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where CKS1BP7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CKS1BP7 is over-expressed in tumor.

BLCA, HNSC, and COAD are the cancer types where CKS1BP7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CKS1BP7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	III,IV	+0.607	<.001	9	view →
HNSC	Male	IV	+0.384	<.001	8	view →
COAD	All	II,III,IV	+0.362	<.001	8	view →
KIRC	All	II,III,IV	+0.171	.004	8	view →
LUAD	Female	All	+0.637	<.001	7	view →
LUSC	All	II,III,IV	+0.417	<.001	6	view →
STAD	All	All	+0.404	.001	6	view →
UCEC	All	All	+0.374	.006	4	view →
LIHC	Female	III,IV	+0.274	.009	3	view →
ESCA	All	II,III,IV	+0.744	.027	2	view →
BRCA	Female	All	+0.141	.043	2	view →
THCA	Male	All	+0.198	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

CKS1BP7–BLCA

Open the BLCA breakdown →